Market revenue in 2023 | USD 16,376.4 million |
Market revenue in 2030 | USD 25,223.1 million |
Growth rate | 6.4% (CAGR from 2023 to 2030) |
Largest segment | Synthetic |
Fastest growing segment | Synthetic |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Synthetic, Biotech |
Key market players worldwide | Dr. Reddy’s Laboratories, Sun Pharmaceutical Industries, Teva Pharmaceutical Industries Ltd, Cipla Ltd DR, AbbVie Inc, Aurobindo Pharma, Sandoz Group AG Registered Shares, Viatris Inc, Fresenius Kabi |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to active pharmaceutical ingredients market will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 70.6% in 2023. Horizon Databook has segmented the Latin America active pharmaceutical ingredients market based on synthetic, biotech covering the revenue growth of each sub-segment from 2018 to 2030.
Countries such as Brazil and Mexico have higher disposable income than other countries in Latin America, which is driving market growth in the region. Improvements in infrastructure and stringent regulatory oversight are boosting the market growth in the region.
Increasing spending by the government to raise awareness about several lifestyle diseases is expected to create growth opportunities for key players in the market. Manufacturing APIs requires high investment, which is one of the factors limiting the growth of local companies in this region.
High capital investments and production costs in this region are expected to limit market growth. Increase in freight prices is a major threat in the region, which has led to an overall increase in API prices.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America active pharmaceutical ingredients market , including forecasts for subscribers. This continent databook contains high-level insights into Latin America active pharmaceutical ingredients market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
No related regions found.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account